Medical Product Outsourcing

Study: Allurion Program Can Resolve Type 2 Diabetes, Hypertension, OSA

Results improved with the addition of an oral GLP-1 agonist semaglutide.

Michael Barbella, Managing Editor 03.20.24

Chronic Disease

Endogenex Gets IDE OK for ReCET Study for Type 2 Diabetes

ReCET is an endoscopic procedure that targets underlying cell pathology in the duodenum.

Sam Brusco, Associate Editor 01.30.24

Chronic Disease

GE HealthCare, Novo Nordisk Partner to Develop Ultrasound Treatment for Type 2 Diabetes, Obesity

The novel technology could specifically regulate metabolic function using ultrasound.

Sam Brusco, Associate Editor 10.19.23

Chronic Disease | Digital Health

Abbott, WeightWatchers Release App for Type 2 Diabetes Patients

WeightWatchers members can access glucose data from FreeStyle Libre 2 while being guided by the plan.

Sam Brusco, Associate Editor 09.19.23

Chronic Disease | Digital Health

DreaMed's Type 2 Diabetes AI Clinical Decision Support Earns FDA Nod

A digital endocrinologist expert-care platform.

Business Wire 10.06.21

Chronic Disease | Digital Health | Patient Monitoring

Teladoc Health, Dexcom Launch CGM Tech, Personalized Insights for Type 2 Diabetes

CGM-powered insights offer complete health profile, recommendations that support ongoing diabetes management.

GlobeNewswire 01.13.21

AVACEN Medical Announces Encouraging Results from Type 2 Diabetes Clinical Study

Results suggest the company's device offers a convenient method for lowering postprandial blood glucose.

AVACEN Medical 01.07.21

Integrity Applications Closes $15 Million Private Placement

Shares were sold for 40 cents each.

Globe Newswire 04.22.20

Chronic Disease | Digital Health

One Drop Acquires Health Sensing Firm Sano

Sano continuous glucose sensing platform will live on in a comprehensive multi-sensorial solution from One Drop.

PR Newswire 04.13.20

Chronic Disease | Patient Monitoring

FDA OKs Abbott's FreeStyle Libre CGM Use in Hospitals

Remotely monitors patients with diabetes to minimize exposure to COVID-19.

PR Newswire 04.08.20

First Patient Enrolled in U.S. STEP-1 Clinical Trial of EndoBarrier

This is the first of 67 patients expected to be enrolled into the first stage of the STEP-1 trial.

Business Wire 03.06.20

Chronic Disease

FDA OKs InPen for Fixed Dosing, Meal Estimation

New bolus calculator considers each user's current glucose level and active insulin.

PR Newswire 02.28.20

FDA Clears t:slim X2 Insulin Pump With Advanced Hybrid Closed-Loop Technology

Automated insulin dosing software is the first to receive new classification by the agency.

Business Wire 02.03.20

Integrity Applications Co-Founder Takes on New Role

The man who helped establish the company is now its president.

Globe Newswire 01.13.20

Bigfoot Biomedical Raises $45M, Led by Abbott

Funds to support breakthrough therapy for 6M living with insulin-requiring type 1 and type 2 diabetes.

Bigfoot Biomedical 01.13.20

Patient Monitoring | Software & IT

Roche's Blood Glucose Reading Smartphone App Gains CE Mark

The app determines blood glucose ranges by taking photos with the smartphone camera without the need for a blood glucose meter.

GlobeNewswire 12.10.19

Diagnostics

One Drop Develops a Model to Predict Blood Glucose Levels for People Using CGMs

Accurately predicts blood glucose levels up to 120 minutes in advance.

PR Newswire 11.19.19

RFPi Awarded Federal Grant to Develop Evaluation Tool for Asymptomatic Patients at Risk of PAD

Funding will help RFPi scientists develop a prototype device that provides a more efficient way to detect peripheral arterial disease.

RFPi Inc. 11.13.19

Digital Health | Patient Monitoring | Software & IT

Abbott and Omada to Develop Type 2 Diabetes Digital Coaching Platform

The solution will combine Abbott's FreeStyle Libre CGM with Omada's digital care program.

Abbott Laboratories 10.14.19

Clinical Trial Evaluating Valeritas’ V-Go Meets Primary A1c Endpoint

Use of regular human insulin could save U.S. type 2 diabetes patients and healthcare systems thousands of dollars per patient annually.

Globe Newswire 10.04.19

Study Shows Real-World Significance of EyeArt AI Eye Screening System From Eyenuk

Data validates the prowess of the EyeArt AI System for diabetic retinopathy screening.

Business Wire 10.02.19

Patient Monitoring

Medtronic Introduces Envision Pro CGM System in Europe

Combines valuable data with optimal user experience.

Medtronic 09.17.19

Apollo Endosurgery Completes Patient Enrollment in MERIT Study

The study is designed to demonstrate weight loss and quality of life at 12 months after the ESG procedure when compared to lifestyle modifications alone.

Business Wire 08.09.19

Diagnostics

Bigfoot Biomedical Partners with Allegheny Health

Plans to advance innovative solutions for diabetics.

Bigfoot Biomedical Inc. 08.01.19

Glytec Developing Solution for Selection and Dosing of All Diabetes Medications

New product will be the market’s first and only to enable optimization of all diabetes medications, insulin and non-insulin alike, according to the company.

Business Wire 07.22.19

Glytec Goes Global, With Six New International Patent Allowances

The company is expanding its IP footprint beyond the U.S., gaining worldwide protections for its proprietary diabetes therapy management solutions.

Business Wire 07.16.19

Glytec Awarded Patent Allowance for Virtual Insulin Titration in Concert With CGM and Smart Pens

Company's digital platform offers primary care providers the means to use CGM data to formulate timely and discrete dosing recommendations.

Business Wire 07.05.19

Patient Monitoring

FDA Warning: Potential Cybersecurity Concerns with Certain Medtronic Insulin Pumps

The recalled pumps are Medtronic’s MiniMed 508 insulin pump and MiniMed Paradigm series insulin pumps.

FDA 06.28.19

Diagnostics

PMLS Offers the DIABETESpredict Test in the U.S.

Premier Medical Laboratory Services, based in Greenville, S.C., is offering the first ever predictive test for type 2 diabetes.

Premier Medical Laboratory Services 06.13.19

Electronics | Patient Monitoring

Medtronic Begins Pivotal Trial for Next-Gen Guardian CGM Sensor

The next-gen sensor aims to improve accuracy and overall system performance, reduce calibrations, and enhance overall user experience.

GlobeNewswire 06.10.19

Digital Health | Patient Monitoring

Remote Patient Monitoring: The 21st Century Approach to Treating Chronic Disease

Employing real-time monitoring technologies to the chronic disease protocol, patients are empowered to become a part of addressing their own medical concerns.

Online Exclusives Waqaas Al-Siddiq, Founder and CEO, Biotricity 05.30.19

Fitbit and Solera Health Expand Partnership to Reduce Risk of Type 2 Diabetes

Solera network participants enrolled in diabetes prevention programs who used Fitbit devices had higher activity levels and increased weight loss.

Business Wire 04.19.19

Medality Medical Receives FDA IDE Approval for Reversal of Type 2 Diabetes Clinical Trial

Company's device is designed to gently and selectively extract excess mesenteric visceral fat, which has been associated with insulin resistance.

Business Wire 04.01.19

Diagnostics

Early Screening Technology Helps Reduce Risk of Liver Disease

A non-invasive device offers the promise of more efficient screening capabilities for earlier detection.

Online Exclusives Laurent Sandrin, Ph.D., Co-Founder, Echosens 03.29.19

GI Dynamics Announces Institutional Review Board Approval for EndoBarrier Pivotal Trial

Trial is designed to measure the efficacy and safety of EndoBarrier in conjunction with lifestyle therapy and diabetes medication for type 2 diabetes treatment.

Business Wire 03.29.19

Digital Health | Patient Monitoring | Software & IT

The Impact of mHealth on the Global Healthcare Fraternity

mHealth is making steady progress as the technology has simplified healthcare for all.

Online Exclusives Shikha Sinha, Global Market Insights 03.20.19

Diagnostics | Software & IT

App Uses Smartphone's Camera & Flashlight to Detect Diabetes

The same technology that tracks heart rate on popular wearable devices may soon screen for diabetes, too.

American College of Cardiology 03.06.19

Monarch Medical Technologies Appoints Expert in Pediatric Diabetes to Medical Advisory Board

New member is a frequent speaker on diabetes and the use of insulin and insulin pump therapy.

Business Wire 03.04.19

GI Dynamics Appoints Vice President of Clinical and Regulatory Affairs

New hire brings over 30 years of experience in development, regulatory, preclinical and clinical operations, quality and resource management to the position.

Business Wire 02.15.19

Diagnostics